Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Under-Expression of LINE-1 Retrotransposons in Chronic Myeloid Leukemia Patients: Effect of Tyrosine Kinase Inhibitors

Beatrice Turcq, MD, Marina Josselin, PhD, Kelly Airiau, PhD, Stéphanie Dulucq, PharmD, Gabriel Etienne, MD PhD, Francis Belloc, PhD, Fabienne Hermitte, PhD, Francois-Xavier Mahon, MD PhD

Blood (2014) 124 (21): 5514.

https://doi.org/10.1182/blood.V124.21.5514.5514

Published: 2014

Journal Articles

Detection of the JAK2 V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2 V617F does not mean absence of myeloproliferative neoplasm

Hélène Peyro-Saint-Paul, Fabienne Hermitte

Blood (2010) 116 (11): 1994–1995.

https://doi.org/10.1182/blood-2010-06-289819

Published: 2010

Journal Articles

JAK2 V617F Evaluation in Healthy Individuals with a Highly Sensitive Quantitative Assay

Christophe Martinaud, Nicolas Maroc, Fabienne Hermitte, PhD, Patrick Brisou, Marie-Joelle Mozziconacci

Blood (2008) 112 (11): 5241.

https://doi.org/10.1182/blood.V112.11.5241.5241

Published: 2008

Journal Articles

A 3′ RACE-PCR Method of Identification of Unknown MLL Gene Partner and Break-Point at RNA Level.

Christine Formisano-Tréziny, Fabienne Hermitte, Benoît Quilichini, Hervé Chambost, Gérard Michel, Jean Gabert

Blood (2006) 108 (11): 4275.

https://doi.org/10.1182/blood.V108.11.4275.4275

Published: 2006

Journal Articles

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Enrico Gottardi, Daniela Cilloni, MD, Sarah Daly, S. Green, Niels Pallisgaard, P. Hokland, MD, M. Ostergaard, C. Nyvold, J. Nomdedeu, MD, Fabrizio Pane, MD, Susanne Schnittger, Vincent Van der Velden, Kalid Tobal, Y. Yin Jal, Fabienne Hermitte, Teo De Witte, R. Hehlmann, Giuseppe Saglio, MD, David Grimwade, MD

Blood (2005) 106 (11): 3295.

https://doi.org/10.1182/blood.V106.11.3295.3295

Published: 2005

NARROW

Under-Expression of LINE-1 Retrotransposons in Chronic Myeloid Leukemia Patients: Effect of Tyrosine Kinase Inhibitors

Detection of the JAK2 V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2 V617F does not mean absence of myeloproliferative neoplasm

JAK2 V617F Evaluation in Healthy Individuals with a Highly Sensitive Quantitative Assay

A 3′ RACE-PCR Method of Identification of Unknown MLL Gene Partner and Break-Point at RNA Level.

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Email alerts

ASH Publications

American Society of Hematology

Under-Expression of LINE-1 Retrotransposons in Chronic Myeloid Leukemia Patients: Effect of Tyrosine Kinase Inhibitors

Detection of the JAK2 V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2 V617F does not mean absence of myeloproliferative neoplasm

JAK2 V617F Evaluation in Healthy Individuals with a Highly Sensitive Quantitative Assay

A 3′ RACE-PCR Method of Identification of Unknown MLL Gene Partner and Break-Point at RNA Level.

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only